Colin Hale

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 170 citations · Full text

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Saye Khoo, Richard J. Fitzgerald, Sean Ewings et al. · Journal of Antimicrobial Chemotherapy · 2021 · 111 citations · Full text

Slug initiation and evolution in two-phase horizontal flow

Priscilla Midah Ujang, C.J. Lawrence, Colin Hale et al. · International Journal of Multiphase Flow · 2006 · 107 citations

Engineering, Fluid Mechanics, Flow Physic +3

Pressure gradient and holdup in horizontal two-phase gas–liquid flows with low liquid loading

S. Badie, Colin Hale, C.J. Lawrence et al. · International Journal of Multiphase Flow · 2000 · 79 citations

Engineering, Fluid Properties, Liquid-liquid Flow +8

The development and validation of a novel LC-MS/MS method for the simultaneous quantification of Molnupiravir and its metabolite ß-d-N4-hydroxycytidine in human plasma and saliva

Alieu Amara, Sujan Dilly Penchala, Laura Else et al. · Journal of Pharmaceutical and Biomedical Analysis · 2021 · 79 citations · Full text

Medicine, Bioanalysis, Antiviral Drug Development +12